LifeStance Health Group Inc. (LFST) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

LifeStance Health Group I... (LFST)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

7.75

0.02 (0.26%)

At close: Jan 14, 2025, 3:59 PM

7.76

0.19%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	7.76
Market Cap	2.96B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.25
PE Ratio (ttm)	-30.98
Forward PE	n/a
Analyst	Buy

Ask	7.99
Volume	629,403
Avg. Volume (20D)	1,493,342
Open	7.77
Previous Close	7.73
Day's Range	7.61 - 7.83
52-Week Range	4.64 - 9.20
Beta	undefined

About LFST

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and p...

[Show more]

Industry Medical - Care Facilities

Sector Healthcare

IPO Date Jun 10, 2021

Employees 7,269

Stock Exchange NASDAQ

Ticker Symbol LFST

Website https://www.lifestance.com

Analyst Forecast

According to 5 analyst ratings, the average rating for LFST stock is "Buy." The 12-month stock price forecast is $9, which is an increase of 16.20% from the latest price.

Buy 60.00%

Hold 20.00%

Sell 20.00%

Stock Forecasts

Next Earnings Release

LifeStance Health Group Inc. is scheduled to release its earnings on Feb 26, 2025, before market opens.
Analysts project revenue of $312.46M, reflecting a 11.35% YoY growth and earnings per share of -0.05, making a -58.33% decrease YoY.

Why Price Moved

1 month ago · Source

+8.09%

LifeStance Health Group shares are trading higher ... Unlock content with Pro Subscription

2 months ago · Source

+7.71%

LifeStance Health shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 revenue guidance above estimates.

News

4 weeks ago · https://thefly.com

Tenet Healthcare downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs analyst Jamie Perse downgraded Tenet Healthcare to Neutral from Buy with a price target of $140, down from $196. Amid rising policy uncertainty, with a wide range of potential outcomes, ...

4 weeks ago · https://thefly.com

LifeStance upgraded to Buy from Neutral at Goldman Sachs

Goldman Sachs upgraded LifeStance to Buy from Neutral with a $10 price target. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a more cautious view on health...

4 weeks ago · https://thefly.com

Universal Health downgraded to Neutral from Buy at Goldman Sachs

Goldman Sachs downgraded Universal Health to Neutral from Buy with a price target of $198, down from $228. Amid rising policy uncertainty, with a wide range of potential outcomes, Goldman is taking a ...

2 months ago · seekingalpha.com

LifeStance Health Group, Inc. (LFST) Q3 2024 Earnings Call Transcript

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chie...

2 months ago · zacks.com

LifeStance Health Group (LFST) Reports Q3 Loss, Tops Revenue Estimates

LifeStance Health Group (LFST) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.17 per share a year ago.